Loading
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (1 ops.)
Latest filing published 30 Mar 2018 for Intellia Therapeutics, Inc., €88k. Read the official filing
Insider track record
Disclosed buys
0
Disclosed sells
1
Signal history
Graeme Bell: trading record in brief
Filings by Graeme Bell span 2 companies, the busiest being Anacor Pharmaceuticals, Inc. and Intellia Therapeutics, Inc. The record holds 6 filings, for trades running from 3 February 2016 to 28 March 2018.
No open-market purchase appears, only 1 sale worth €67k. Outside the open market, there are 3 share grants and 1 option exercise.
On 30 March 2018 came the latest disclosure, an option exercise for €88k in Intellia Therapeutics, Inc. Typically, a trade is published a median of 2 days after it takes place. The legal deadline for a Form 4 is two business days after the transaction. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Graeme Bell
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations6 total
8,000 shares@ US$13.4831.9% of flowCommon StockSEC:0001209191-18-022178:0
5,000 shares@ US$22.0434.4% of flowCommon StockSEC:0001209191-17-059054:0
8,400 shares@ US$12.3733.7% of flowCommon StockSEC:0001209191-17-037516:0
10,488 shares@ US$99.2593.2% of flowCommon StockSEC:0000950103-16-014334:0
751 shares@ US$99.286.8% of flowCommon StockSEC:0001209191-16-125860:0
5,000 sharesCommon StockSEC:0001209191-16-096102:0
6 of 6 declarations
